[go: up one dir, main page]

AR064419A1 - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
AR064419A1
AR064419A1 ARP070105696A ARP070105696A AR064419A1 AR 064419 A1 AR064419 A1 AR 064419A1 AR P070105696 A ARP070105696 A AR P070105696A AR P070105696 A ARP070105696 A AR P070105696A AR 064419 A1 AR064419 A1 AR 064419A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
pharmaceutically acceptable
pharmaceutical composition
acceptable acid
gelatin capsule
Prior art date
Application number
ARP070105696A
Other languages
English (en)
Original Assignee
Rosenberg Tanja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37890457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR064419(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rosenberg Tanja filed Critical Rosenberg Tanja
Publication of AR064419A1 publication Critical patent/AR064419A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica en la forma de una cápsula de gelatina, la cual comprende un ácido farmacéuticamente aceptable.
ARP070105696A 2006-12-20 2007-12-18 Composiciones farmaceuticas AR064419A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06126698 2006-12-20

Publications (1)

Publication Number Publication Date
AR064419A1 true AR064419A1 (es) 2009-04-01

Family

ID=37890457

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105696A AR064419A1 (es) 2006-12-20 2007-12-18 Composiciones farmaceuticas

Country Status (15)

Country Link
US (1) US20100068265A1 (es)
EP (1) EP2120889A1 (es)
JP (1) JP2010513351A (es)
KR (1) KR20090094373A (es)
CN (1) CN101563072A (es)
AR (1) AR064419A1 (es)
AU (1) AU2007334856A1 (es)
BR (1) BRPI0720489A2 (es)
CA (1) CA2672400A1 (es)
CL (1) CL2007003698A1 (es)
MX (1) MX2009006735A (es)
PE (1) PE20081482A1 (es)
TW (1) TW200833375A (es)
UY (1) UY30810A1 (es)
WO (1) WO2008074479A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2803558C (en) 2010-06-30 2018-05-29 Mochida Pharmaceutical Co., Ltd. .omega.3 fatty acid compound preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
DE4001622A1 (de) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
US5620704A (en) * 1994-11-07 1997-04-15 Warner-Lambert Company Process for stabilizing gelatin products
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1997033568A1 (en) * 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6228894B1 (en) * 1998-04-17 2001-05-08 Enhanced Derm Technologies, Inc. Softgel-compatible composition containing retinol
ATE387191T1 (de) * 2002-04-25 2008-03-15 Banner Pharmacaps Inc Kaubare weichkapsel
WO2003103582A2 (en) * 2002-06-05 2003-12-18 Ivax Corporation Reduction of gelatin cross-linking

Also Published As

Publication number Publication date
TW200833375A (en) 2008-08-16
CL2007003698A1 (es) 2008-07-18
EP2120889A1 (en) 2009-11-25
PE20081482A1 (es) 2008-12-23
KR20090094373A (ko) 2009-09-04
BRPI0720489A2 (pt) 2014-02-04
CA2672400A1 (en) 2008-06-26
JP2010513351A (ja) 2010-04-30
UY30810A1 (es) 2008-07-31
US20100068265A1 (en) 2010-03-18
AU2007334856A1 (en) 2008-06-26
CN101563072A (zh) 2009-10-21
WO2008074479A1 (en) 2008-06-26
MX2009006735A (es) 2009-06-30

Similar Documents

Publication Publication Date Title
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
MX2009010289A (es) Composiciones para administracion nasal.
EP1984009A4 (en) PHARMACEUTICAL COMPOSITIONS WITH IMPROVED STABILITY
BRPI0810646A2 (pt) " compostos farmacêuticos ".
DE602007003074D1 (de) Neue pyrinderivate
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
MY154909A (en) Novel thiophene derivatives
AR033711A1 (es) Composiciones farmaceuticas
WO2007143651A3 (en) Chewable co-enzyme q-10 capsule
EP2246052A4 (en) RASCH IN THE MOUTH DAMAGING TABLET WITH IMIDAFENACIN
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
JP2009537554A5 (es)
EA201170512A1 (ru) Композиция для перорального введения
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
WO2006138735A3 (en) Gel compositions for topical administration
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
IT1401284B1 (it) Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system).
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
SM200500011B (it) Una composizione farmaceutica antimicobatterica
AR064419A1 (es) Composiciones farmaceuticas
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин

Legal Events

Date Code Title Description
FB Suspension of granting procedure